| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
myocyte enhancer factor 2B | 0.670 | 0.308 | 9.3E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
thioredoxin reductase 2 | 0.548 | 0.731 | 3.5E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
dedicator of cytokinesis 11 | 0.606 | 0.731 | 1.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
ankyrin repeat and fibronectin type III domain containing 1 | 0.890 | 0.154 | 2.1E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
YTH N6-methyladenosine RNA binding protein 3 | 0.780 | 0.308 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
SEC14 like lipid binding 3 | 0.722 | 0.500 | 3.7E-23 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | ||||||||
|
growth hormone secretagogue receptor | 0.528 | 0.769 | 6.6E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
G protein subunit alpha 11 | 0.563 | 0.731 | 0.89 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2002 | 2002 | ||||||||
|
interferon lambda 3 | 0.506 | 0.808 | 2.4E-08 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
T cell receptor beta variable 20-1 | 0.821 | 0.346 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | |||||||||
|
general transcription factor IIB | 0.769 | 0.308 | 1.2E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
general transcription factor IIH subunit 4 | 0.573 | 0.846 | 4.2E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2007 | 2007 | ||||||||
|
interferon gamma inducible protein 16 | 0.603 | 0.769 | 1.8E-11 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 | 0.700 | 0.500 | 4.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
myosin IXB | 0.644 | 0.615 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2009 | 2009 | ||||||||
|
T cell receptor associated transmembrane adaptor 1 | 0.615 | 0.692 | 5.6E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
inositol-3-phosphate synthase 1 | 0.510 | 0.769 | 2.5E-05 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
acyl-CoA thioesterase 13 | 0.729 | 0.423 | 3.1E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 | ||||||||
|
protein kinase N2 | 0.711 | 0.423 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
twinkle mtDNA helicase | 0.516 | 0.692 | 3.2E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
protein tyrosine phosphatase receptor type M | 0.821 | 0.192 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
PVR cell adhesion molecule | 0.510 | 0.769 | 3.9E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2004 | 2004 |